Sign in
8-K

Current Report

KYNTRA BIO, INC. Filed Acc 0000950170-23-033458

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading fgen-20230714.htm…